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Introduction {#sec004}
============

Syncope is defined by the ACC/AHA/HRS Syncope Guideline as "an abrupt, transient, complete loss of consciousness and postural tone, secondary to inadequate cerebral perfusion" \[[@pone.0219598.ref001]\]. The onset of syncope is relatively rapid, and the subsequent recovery is spontaneous, complete, and relatively prompt. It is a common pathology, representing around 5% of hospital admissions, 3% of emergency unit visits \[[@pone.0219598.ref002]\] and 1 to 3% of pediatrics emergency department visits \[[@pone.0219598.ref003]\]. Despite their brief and benign nature, frequent reflex syncope can influence the quality of life of patients \[[@pone.0219598.ref004]\] and reflex syncope in children is a source of stress for their parents. They may be anxious and consider that their child has either stopped breathing and many will pick their child up or attempt cardiopulmonary resuscitation, or both \[[@pone.0219598.ref005]\].

Reflex (or neutrally-mediated) syncope is defined as "a syncope due to a reflex that causes vasodilation, bradycardia or both" \[[@pone.0219598.ref001]\]. Vasovagal syncope, the most common form of reflex syncope mediated by the vasovagal reflex and associated to cerebral hypoperfusion and triggered by emotion or orthostatic stress, is usually preceded by prodromal symptoms of autonomic system activation (sweating, pallor, or nausea) \[[@pone.0219598.ref001],[@pone.0219598.ref006]\]. Vagal overactivity (VO), with an inappropriate reflex implicating afferent, central, and efferent pathways, seems to be involved in the reflex syncope, particularly in vasovagal syncope \[[@pone.0219598.ref007]\]. The vagal nervous system is considered as having a protective role \[[@pone.0219598.ref008]\], balancing the sympathetic influence on the cardiac rhythm \[[@pone.0219598.ref007]\]. The cardiac vagus influences heart function through the sinus node and also through intraventricular parasympathetic fibers which are likely to add their effects on those of the fibers terminating in the sinus node \[[@pone.0219598.ref009]\]. In addition, there are muscarinic receptors in cardiomyocytes \[[@pone.0219598.ref010]\].

So far, no biological abnormalities were identified in reflex syncope. Our hypothesis is that biological abnormalities of the cholinergic system are associated with clinical manifestations of VO such as reflex syncope. The biological substrate of a VO could be i) exaggerated production and release of the neurotransmitter, acetylcholine; ii) abnormally high density of muscarinic M receptors (M~2~R) specific to acetylcholine; iii) abnormally low enzymatic inactivation of acetylcholine by the acetylcholinesterase (AchE). The measurement of acetylcholine in real time is neither easy nor reliable. Thus, we tested the hypothesis of muscarinic receptor overexpression, first in an experimental model of vagal hyperactivity \[[@pone.0219598.ref011]\] and an abnormally high muscarinic receptor density was observed in the myocardium of rabbits presenting VO \[[@pone.0219598.ref011],[@pone.0219598.ref012]\]. We have observed a good correlation between the muscarinic receptor density and the ECG R-R intervals, *i*.*e*. inverse correlation with the heart rate. This observation concerned the M~2~ and M~3~ subtypes of muscarinic receptors expressed in the heart of rabbits. But it was for the M~2~ receptors (M~2~R) that the correlation was the best \[[@pone.0219598.ref012]\]. For the rest of our exploratory work in this area, we focused on the M~2~ subtype. For our work in humans, we had one more reason to focus on this subtype; it is the subtype mainly expressed in the human myocardium \[[@pone.0219598.ref013]\]. M~2~R overexpression was most often accompanied by an unexpected increase of AchE expression or activity \[[@pone.0219598.ref012],[@pone.0219598.ref014]\]. This AchE abnormality was interpreted as a possible compensatory response to M~2~R overexpression. Both abnormalities were found in the white blood cells of the rabbit VO model \[[@pone.0219598.ref012]\]. Muscarinic receptors, including M~2~R, are expressed in lymphocytes and their mRNAs were detected in the majority of mononuclear immune cells with a significant variability among subjects \[[@pone.0219598.ref015],[@pone.0219598.ref016]\]. So far, no plasma M~2~R have been identified. M~2~R overexpression and AchE overexpression were also observed in hearts of infants deceased from Sudden Infant Death Syndrome (SIDS) \[[@pone.0219598.ref014]\]~.~

The present study aimed at testing whether M~2~R overexpression could be associated with VO in a relatively common clinical situation, namely reflex or neutrally-mediated syncope, usually uncomfortable in adults and possibly harmful in children \[[@pone.0219598.ref017]\].

Methods {#sec005}
=======

Study design {#sec006}
------------

This study was a monocenter, pathophysiological, and comparative study. Adult patients exhibiting recurrent reflex syncope, *i*.*e*. at least 3 episodes, were compared to healthy adult volunteers. Children exhibiting reflex syncope requiring hospitalization or medical consultation were compared to hospitalized children with neither history of syncope nor cardiac pathology. The adult and children subjects were recruited from the Clinical Investigation Center, adult cardiology unit, and pediatrics unit.

Study approval {#sec007}
--------------

This study was performed in accordance with the principles of the Declaration of Helsinki and the guidelines for Good Clinical and Laboratory Practice. The study was approved by the institutional review board of the Comité de Protection des Personnes-Est IV, Strasbourg, France (N° IDRCB 2010-A01451-38) and recorded in ClinicalTrials.gov (NCT01358461). The authors designed and conducted the study, managed the database, and wrote all drafts of the manuscript. All the authors vouch for the accuracy and completeness of the data and reported analyses, as well as for the study's adherence to the protocol.

Subjects {#sec008}
--------

We recruited 136 subjects in this study at the University Hospital of Strasbourg. All subjects met the inclusion and exclusion criteria ([Table 1](#pone.0219598.t001){ref-type="table"}) and completed all assessments. 83 patients with reflex syncope were compared to 53 control subjects with no current or history of syncope. Pediatric patients, 38 children; age range: \[1 to 18 years\], were enrolled in pediatric unit after medical consultation for reflex syncope. 21 control children were selected in the cardio-pediatric unit after examination of medical history. 45 Adult patients \[18 to 50 years\] were enrolled in the cardiology unit after medical consultation for recurrent reflex syncope. 32 healthy adult volunteers were recruited for control adult group. All adult subjects and the parents or guardians of the minors were informed orally and writing of the study's modalities and signed consent. Adult subjects received a financial compensation for this study.

10.1371/journal.pone.0219598.t001

###### Detailed inclusion and exclusion criteria for enrollment in the study.

![](pone.0219598.t001){#pone.0219598.t001g}

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                           Inclusion criteria                                                                                  Exclusion criteria
  ------------------------ --------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------
  **Adult patients**       Men or women aged 18 to 50\                                                                         Cardiovascular, neurological, psychiatric, immunologic, infectious or metabolic diseases\
                           Patients with clinical signs of recurrent reflex syncope (\>3 episodes)\                            Dysautonomia\
                           Normal electrocardiogram\                                                                           Ongoing treatment targeting the autonomic nervous system\
                           Normal blood count\                                                                                 Consumption of doping agents or addiction (cocaine, cannabis, amphetamines, alcohol...)\
                           No contraindication for the carotid sinus massage test in carotid Doppler echography\               Consumption of tobacco, coffee, within the 24 hours before the clinical and laboratory investigations\
                           Non-smoking or occasional smoking (\<3 per day)                                                     Pregnancy or breastfeeding

  **Adult controls**       Men or women aged 18 to 50\                                                                         
                           No history of reflex syncope or cardiac diseases\                                                   
                           Normal electrocardiogram\                                                                           
                           Normal blood count\                                                                                 
                           No contraindication for the carotid sinus massage test in carotid Doppler echography\               
                           Non-smoking or occasional smoking (\<3 per day)                                                     

  **Pediatric patients**   Males or females aged 1 to 18\                                                                      
                           Patients with clinical signs of reflex syncope requiring hospitalization or medical consultation\   
                           Normal electrocardiogram\                                                                           
                           Normal blood count\                                                                                 
                           Non-smoking or occasional smoking (\<3 per day)                                                     

  **Pediatric controls**   Males or females aged 1 to 18\                                                                      
                           No history of reflex syncope or cardiac diseases\                                                   
                           Normal electrocardiogram\                                                                           
                           Normal blood count\                                                                                 
                           Non-smoking or occasional smoking (\<3 per day)                                                     
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Study endpoints {#sec009}
---------------

The primary endpoint was M~2~R mRNA expression in the blood of adults and children exhibiting reflex syncope. The secondary endpoint was AchE mRNA blood expression.

Study assessments {#sec010}
-----------------

The selection visit was conducted by a cardiologist, involving clinical examinations, medical history, current treatment, electrocardiogram, and echo-Doppler of carotid arteries (for subjects over 40 years of age). During the following visit, Holter electrocardiographic monitoring was carried out in all adult subjects (see [S1 File](#pone.0219598.s001){ref-type="supplementary-material"} for assessment details and interpretation criteria). Holter electrocardiographic, usually performed in case of recurrent syncope, was considered positive (significant vagal overactivity) when squared differences between adjacent normal RR intervals (RMSSD) were higher than 56 milliseconds (ms) in males and 62ms in females and when the percentage of adjacent intervals over 50 ms (PNN50) was higher than 28% in males and 29% in females \[[@pone.0219598.ref018],[@pone.0219598.ref019]\]. A carotid sinus massage test (CSMT) was also performed in adult subjects. In this study the CSMT was performed by manually massaging for 5 to 10 seconds the anterior sternocleidomastoid muscle on a motorized inclination table (Genin-France) with continuous blood pressure blood monitoring (in accordance with the FinapressTM instructions) and the heart rate (Task Force Monitor, CNS system, Graz, Austria). CSMT was suggestive of exaggerated parasympathetic activity when the heart rate reduction in response to carotid massage was greater than 10% or the mean arterial pressure decreased by more than 20% compared to the baseline \[[@pone.0219598.ref020]\].

Two blood samples were collected from each subject for the complete blood count and mRNA specific analysis (M~2~R and AchE). For the complete blood count, 4mL of peripheral blood were sampled. Assessments were performed in the hematology laboratory of Strasbourg University Hospital. The second blood sample (2.5mL) was collected in PaxGene Blood RNA Tubes according to Qiagen recommendations. Total RNA was extracted automatically by Qiacube with the PaxGene RNA kit (Qiagen); 200ng of total RNA were reverse transcribed into cDNA, using the iScript cDNA Synthesis kit (Biorad). Target gene expressions were measured by quantitative real-time polymerase chain reaction (qRT-PCR) using a specific primer for the target genes: CHRM2 for M~2~R and ACHE for AchE. The relative concentrations of the target genes were calculated using a standard range created from a pool of 70 RNA of healthy subjects. The housekeeping gene (HKG) ribosomal 18S RNA was employed for the normalization of the expressions \[[@pone.0219598.ref021],[@pone.0219598.ref022]\], the same as that used in our previous studies for the same purpose \[[@pone.0219598.ref012],[@pone.0219598.ref014]\]. M~2~R and AchE expressions normalized by 18S are expressed as arbitrary units (a.u.). The samples were analyzed in a blinded procedure. Detailed laboratory data are provided as Supporting Information, [S1 Methods](#pone.0219598.s002){ref-type="supplementary-material"}.

Statistics {#sec011}
----------

The initial characteristics of patients were described in each group by means and standard error of the mean or effectives, depending on the nature of each variable: quantitative or categorical. Results were expressed as median with 25 and 75 quantiles (also in box plot graphs) for continuous variables or number of individuals (and frequency) of each modality for qualitative variables.

To model the studied normalized values, *e*.*g*. M~2~R:18S, in both groups, generalized linear models with Gamma distribution (and a logarithmic link function) were used, for dealing with strictly positive yet asymmetric values, thus attributing less weight to extreme values. More specifically, the mean of a normalized value was explained additively by a grand mean and a group effect. Statistical inference was carried out using Bayesian technics \[[@pone.0219598.ref023]\].

Markov Chain Monte Carlo (MCMC) methods with one chain, 5,000 burn-in iterations and 100,000 iterations were used for generating samples of posterior distributions. Estimate for the model coefficients have been presented as mean and \[95% credible interval\] from each posterior distribution. Convergence of the chains was checked in every case. Minimally informative prior distributions were chosen as normal distribution with zero mean and a variance of ten for the parameters in regression models \[[@pone.0219598.ref023]\]. The probability for the group parameter to be strictly positive, *i*.*e*. the probability of observing a positive difference between groups, was estimated from the quantiles of its posterior distribution. According to the context of this study, such a probability greater than 0.90 was considered to be strongly relevant. All analyses were performed using R software \[[@pone.0219598.ref024]\].

Results {#sec012}
=======

The characteristics of the subjects have been presented in [Table 2](#pone.0219598.t002){ref-type="table"}. All detailed results are available in [Supporting Information]{.ul}.

10.1371/journal.pone.0219598.t002

###### Characteristics of the study subjects.

![](pone.0219598.t002){#pone.0219598.t002g}

                                               Patients                                            Controls                              
  -------------------------------------------- --------------------------------------------------- ------------ ------------ ----------- ----
  **Number of subjects**                       45                                                  38           32           21          
  **Total**                                    83                                                  53                                    
  **Number of subjects by gender**             **Females**                                         38           20           12          8
  **Total**                                    58                                                  20                                    
  **Males**                                    7                                                   18           20           13          
  **Total**                                    25                                                  33                                    
  **Age in inclusion (mean +/- SEM years)**    27·3 ± 8·6                                          8·8 ± 4·8    24·8 ± 5·4   7·7 ± 3·6   
  **Total (mean +/- SEM years)**               18·9 ± 11·7                                         18·0 ± 9·7                            
  **Carotid Sinus Massage Test**               **Positive**[\*](#t002fn002){ref-type="table-fn"}   34           NA           8           NA
  **Negative**                                 10                                                  24                                    
  **Holter electrocardiographic monitoring**   **Positive[†](#t002fn003){ref-type="table-fn"}**    16           NA           6           NA
  **Negative**                                 28                                                  26                                    

SEM: standard error of the mean

\*: CSMT was suggestive of exaggerated parasympathetic activity, when the heart rate reduction in response to carotid massage was greater than 10% or mean arterial pressure decreased by more than 20% compared to the baseline.

†: A Holter test was considered positive (significant vagal activity) when rMSSD was higher than 56ms in males and 62ms in females and when PNN50 was higher than 28% in males and 29% in females.

M~2~R and AchE expression in the pooled groups of subjects (adults and children) ([Fig 1](#pone.0219598.g001){ref-type="fig"}) {#sec013}
------------------------------------------------------------------------------------------------------------------------------

The medians \[q1; q3 interval\] of M~2~R expression level were 0.2 \[0.1; 1.0\] in the control group and 0.9 \[0.3; 1.9\] in the patient group, including children and adults. The probability that M~2~R expression was greater in the patient group than in the control group was estimated at Pr\[patients \>controls\] = 0.99 in this group ([Fig 1A](#pone.0219598.g001){ref-type="fig"}).

![mRNA expression of muscarinic M~2~ receptors (M~2~R), acetylcholinesterase (AchE) and ratio of M~2~R/AchE mRNA expression in the pooled groups of subjects (on log-scale).\
**A**:Medians of mRNA M~2~R expression with 25 and 75 percentiles in box plots based on all subject data, along with the probability that M~2~R expression is greater in the patient group than the control group \[Pr(patients\>controls)\], estimated from the posterior distribution in regression models **B:** Medians of mRNA AchE expression with 25 and 75 percentiles in box plots based on all subject data, and the probability that AchE expression is greater in the patient group than the control group \[Pr(patients\>controls)\], estimated from the posterior distribution in regression models.](pone.0219598.g001){#pone.0219598.g001}

The medians of AchE expression were 0.4 \[0.2; 1.1\] in the control group and 0.7 \[0.4; 1.6\] in the patient group, with probability of superiority Pr\[patients \>controls\] = 0.97 ([Fig 1B](#pone.0219598.g001){ref-type="fig"}).

M~2~R:AchE expression ratio ([S1 Fig](#pone.0219598.s023){ref-type="supplementary-material"}) {#sec014}
---------------------------------------------------------------------------------------------

The medians of the M~2~R:AchE ratio were 0.8 \[0.5; 1.1\] in the control group and 1.1 \[0.8; 1.3\] in the patient group. The probability that the M~2~R:AchE expression ratio was greater in the patient group than in the control group was estimated at Pr\[patients \>controls\] = 1.00 for all the patients.

Correlations {#sec015}
------------

No strong correlations were found between the M~2~R expression and the number of syncope (measured by the lifetime cumulative events of syncope), age of subject or gender. The same applied for AchE expression.

M~2~R and AchE mRNA expression in the adult group ([Fig 2](#pone.0219598.g002){ref-type="fig"}) {#sec016}
-----------------------------------------------------------------------------------------------

When adults were analyzed separately, we found very similar results. In brief, the probability that M~2~R expression was greater in the patient group 0.9 \[0.1; 2.0\] than in the control group 0.2 \[0.1; 0.8\] was estimated at Pr\[patients \>controls\] = 0.98 ([Fig 2A](#pone.0219598.g002){ref-type="fig"}).

![Expressions of M~2~R and AchE in the adult group (on log-scale).\
**A**: Medians of mRNA M~2~R expression with 25 and 75 percentiles in box plots based on adult group data, along with the probability that M~2~R expression is greater in the patient group than the control group \[Pr(patients\>controls)\], estimated from the posterior distribution in regression models **B**: Medians of mRNA AchE expression with 25 and 75 percentiles in box plots based on adult group data, and the probability that AchE expression is greater in the patient group than the control group \[Pr(patients\>controls)\], estimated from the posterior distribution in regression models **C**: Medians of mRNA M~2~R expression with 25 and 75 percentiles in box plots based on adult group data, along with the probability that M~2~R expression is greater in the patient group than the control group \[Pr(patients\>controls)\], estimated from the posterior distribution in regression models. The results of the Carotid Sinus Massage Test (CSMT) are considered: CSMT(-) for a negative test and CSMT (+) for a positive test. **D**: Medians of mRNA AchE expression with 25 and 75 percentiles in box plots based on adult group data, and the probability that AchE expression is greater in the patient group than the control group \[Pr(patients\>controls)\], estimated from the posterior distribution in regression models. The results of the Carotid Sinus Massage Test (CSMT) are considered: CSMT(-) for a negative test and CSMT (+) for a positive test.](pone.0219598.g002){#pone.0219598.g002}

The medians of AchE expression were 0.8 \[0.4; 2.1\] in the patient group and 0.4 \[0.2; 1.1\] in the control group, with a probability of superiority for the patients estimated at Pr\[patients \>controls\] = 0.97 in the adult patients ([Fig 2B](#pone.0219598.g002){ref-type="fig"}).

M~2~R:AchE expression ratio in the adult group ([S2 Fig](#pone.0219598.s024){ref-type="supplementary-material"}) {#sec017}
----------------------------------------------------------------------------------------------------------------

The probability that the M~2~R: AchE expression ratio was greater in the patient group than in the control group was estimated at Pr\[patients \>controls\] = 0.98 in adults. The medians were 1.1 \[0.7; 1.3\] and 0.8 \[0.5; 0.9\] in patients and controls, respectively.

Carotid sinus massage test and Holter electrocardiographic monitoring ([Fig 2](#pone.0219598.g002){ref-type="fig"}) {#sec018}
-------------------------------------------------------------------------------------------------------------------

When including the carotid sinus massage test (CSMT) data, the results were even more pronounced. The probability that M~2~R mRNA expression was greater in the patient group with positive CSMT (1.0 \[0.4; 2.1\]) than in the control group with negative CSMT (0.1 \[0.1; 1.1\]) was estimated at Pr\[patients \>controls\] = 0.99. As for AchE expression, this probability was estimated at 0.98. The medians were 1.0 \[0.5; 1.9\] in the patient group (with positive CSMT) and 0.3 \[0.2; 1.2\] in the control group (with negative CSMT) ([Fig 2C and 2D](#pone.0219598.g002){ref-type="fig"}).

As for the Holter electrocardiographic monitoring results, alone or with CSMT results, the probabilities were lower (detailed results in [Supporting Information]{.ul}).

M~2~R and AchE mRNA expression in the pediatric group ([Fig 3](#pone.0219598.g003){ref-type="fig"}) {#sec019}
---------------------------------------------------------------------------------------------------

In children, the probability that M~2~R expression was greater in the patient group 1.0 \[0.3; 1.6\] than in the control group 0.3 \[0.2; 1.1\] was estimated at Pr\[patients \>controls\] = 0.90 ([Fig 3A](#pone.0219598.g003){ref-type="fig"}).

![Expressions of M~2~R and AchE in the pediatric group (on log-scale).\
**A**: Medians of mRNA M~2~R expression with 25 and 75 percentiles in box plots based on pediatric group data, along with the probability that M~2~R expression is greater in the patient group than the control group \[Pr(patients\>controls)\], estimated from the posterior distribution in regression models **B**: Medians of mRNA AchE expression with 25 and 75 percentiles in box plots based on pediatric group data, and the probability that AchE expression is greater in the patient group than the control group \[Pr(patients\>controls)\], estimated from the posterior distribution in regression models.](pone.0219598.g003){#pone.0219598.g003}

The medians of AchE expression were 0.7 \[0.4; 1.1\] in the patient group and 0.5 \[0.4; 1.1\] in the control group, with a probability for superiority in the patient group in the pediatric group Pr\[patients \>controls\] = 0.74 ([Fig 3B](#pone.0219598.g003){ref-type="fig"}).

M2R: AchE expression ratio in the pediatric group ([S3 Fig](#pone.0219598.s025){ref-type="supplementary-material"}) {#sec020}
-------------------------------------------------------------------------------------------------------------------

The probability that the M~2~R:AchE expression ratio was greater in the patient group 1.2\[0.8; 1.6\] than in the control group (1.1\[0.6; 1.3\]) was estimated at Pr\[patients \>controls\] = 0.97.

Discussion {#sec021}
==========

From the beginning, we considered the prospect of future development of a blood marker, and for this purpose, we relied on the studies of the Kawashima\'s group, demonstrating the existence of a complete cholinergic system, including muscarinic receptors and AchE, in lymphocytes. In addition, our first studies in rabbits and in cases of SIDS showed the similarity between what we observed in the heart and in nuclear blood cells \[[@pone.0219598.ref012],[@pone.0219598.ref014]\].

According to our previous studies, all types of muscarinic receptors seem to be increased in blood; in this study, we focused our research in the M~2~ subtype, which is mostly expressed in the heart \[[@pone.0219598.ref012]\]. M~2~R mRNA was largely overexpressed in the child and adult patients compared to the controls. These findings confirm the study's primary objective. AchE mRNA was also increased in patients compared to controls, although greater difference was observed in adults than in children. There was no correlation between M~2~R or AchE expression and age, gender or number of syncope.

It is important to note that two previous studies from our team, have shown that mRNA expression (qRT-PCR) and protein expression (binding experiments) follow parallel changes \[[@pone.0219598.ref012],[@pone.0219598.ref014]\]. In other words, mRNA expression clearly results in protein translation in the case of M~2~R proteins. Therefore, using qRT-PCR technique to assess M~2~R expression was justified \[[@pone.0219598.ref025]\]. The same applied for mRNA and AchE expression. The qRT-PCR is an accurate and sensitive method to quantify gene expression. To reduce factors which can diminish RT-PCR accuracy, *e*.*g*. quality of RNA, cDNA synthesis by reverse transcriptase, PCR amplification efficiencies, reference genes, known as HKG, are used as internal controls for normalizing the relative expression of target genes \[[@pone.0219598.ref021],[@pone.0219598.ref022]\]. In this study, we used the 18S ribosomal gene as a HKG, which was used previously \[[@pone.0219598.ref012],[@pone.0219598.ref014],[@pone.0219598.ref017]\]. Our previous studies have also shown a correlation between cardiac M~2~R density and M~2~R mRNA expression in blood, the same overexpressions were found in heart and in blood \[[@pone.0219598.ref012]\]. Based on this background and for practical reasons, the mRNA expression was assessed in the blood of all the subjects. We took 2.5mL whole blood samples using PaxGene tubes that enabled rapid and easy analysis.

It is interesting to note that in our study M~2~R overexpression was assessed in blood, confirming that the muscarinic dysfunction is not restricted to the heart as previously reported \[[@pone.0219598.ref012],[@pone.0219598.ref014]\]. As mentioned above, all elements of a cholinergic system are expressed in lymphocytes, *i*.*e*. synthesis and degradation enzymes of acetylcholine and various muscarinic receptors \[[@pone.0219598.ref015],[@pone.0219598.ref016]\]. But it is possible that, in addition, there might be interactions between peripheral muscarinic receptors and the vagal system that remain to be explored. Our results suggest that, subject to validation, M~2~R overexpression could become a biological marker of VO.

In this exploratory work, we aimed to exhaustively measure the expression of different forms of AchE and to do so we designed oligonucleotides common for all three isoforms of AchE (E,S and R) \[[@pone.0219598.ref026],[@pone.0219598.ref027]\]. We experimentally measured mRNA expression in white blood cells (WBC) and eventually that of red blood cells (RBC). We employed the HKG ribosomal 18S for normalization; therefore, the mRNA expression in WBC (or eventually RBC) does not vary with their number. Future studies could be devoted to the expression of the 3 AchE variants. The significant AchE overexpression observed, at least in adults, strengthens the hypothesis that this is a compensatory mechanism secondary to M~2~R overexpression itself. In children, AchE was also overexpressed, albeit to a lesser extent than in adults, suggesting that the above-mentioned compensatory mechanism is not fully mature at that development stage, whereas M~2~R expression abnormality occurs very early in life \[[@pone.0219598.ref014],[@pone.0219598.ref017]\].

In our patients, the average M~2~R/AchE expression ratio was higher than in controls for the total subjects, as well as in adult and pediatric subgroups. These ratio differences indicate that the increase in M~2~R expression is more relevant than that of AchE. These results suggest that, in patients, the compensatory increase of AchE expression could be insufficient to prevent syncope. Finally, the combination of M~2~R overexpression and incomplete compensation by AchE overexpression might be the mechanism behind reflex syncope, particularly the very severe equivalent of reflex syncope in infants \[[@pone.0219598.ref017]\].

In some situations, particularly in infants, the expression of M~2~R can be highly increased whereas the increase of the enzyme expression is not as important \[[@pone.0219598.ref017]\]; therefore, the hypothesis according to which the overexpression of the AchE could be the primary phenomenon which in turn would induce an upregulation of the M~2~R can be precluded. We propose this compensatory mechanism as a hypothesis. Biologically, it remains to demonstrate that the increase in the expression of M~2~R and that of AchE originate in the same cell type. In any case, our results show that, at least on the functional point of view, there is a compensatory association, complete or partial according to the clinical situations, between the two phenomena. As in children especially those with iALTE, the overexpression of the AchE is much less than that of the M~2~R, it is tempting to assume that the overexpression of the AchE is sometimes insufficient to compensate that of M~2~R. Our results are compatible with the hypothesis of a systemic dysfunction of the cholinergic system in this pathology.

As already mentioned in the introduction, our results do not exclude that a sympathetic dysregulation can be the primary cause of the dysfunction of the sympatho-vagal balance \[[@pone.0219598.ref028]\]. But our results support the hypothesis according to which VO could be the final common pathway of vagal hyperactivity.

Especially in the adult subjects, the blood samples were collected at different times in relation to their last syncope. In some cases, blood has been collected quite a long period afterwards. This could generate variability and thus a loss of power and sensitivity in the dosing of the expression of M~2~R and AchE. Thus, the question of whether these biological abnormalities are a transient rather than a permanent process remains open. To answer this question, a longitudinal study should be conducted to assess these biological parameters at different time intervals after the last syncope.

Carotid sinus massage test (CSMT) is a functional test often used in adults with syncope of unknown origin, but possibly reflex syncope \[[@pone.0219598.ref001]\]. In our study, a CSMT was systematically performed in all subjects, who did not have any contraindication to assess carotid sinus hypersensitivity associated with vagal parasympathetic overactivity. As a matter of fact, the difference in M~2~R expression between the two adult groups was even more significant when not only clinical criteria but also CSMT data were considered. This observation confirms that CSMT is suitable for testing VO, at least via M~2~R expression assessment, whereas Holter data does not influence the difference. To homogenize our patient selection, we could have used positive CSMT as a selection criterion, in addition to clinical parameters \[[@pone.0219598.ref029]\]. However, no relationships between CSMT, VO, and M~2~R density had previously been demonstrated. Our findings highlight such relationships and thus indicate that CSMT could be used in future studies in this domain.

Limitations {#sec022}
-----------

Several limitations of our study should be noted. Our results on M~2~R are consistent with a coherent pathophysiology scenario concerning reflex syncope. However, they do not exclude the involvement of other biological parameters, *i*.*e*. neuromediators such as adenosine \[[@pone.0219598.ref030],[@pone.0219598.ref031]\], receptors, enzymes, hormones. In other words, the pathophysiology of the neuro-mediated syncope might be more complex than the only overexpression of muscarinic receptors They are mainly located in the cardiac atria and are primarily responsible for slowing the heart rate. Long lasting cardiac pauses as a consequence of the M~2~R overexpression may explain syncope; M~2~R are also expressed in the vascular walls \[[@pone.0219598.ref032]\]. Whether or not vascular M~2~R overexpression may also contribute to syncope still remains to be investigated.

A quite great inter-individual variability of M~2~R and AchE expression in each group was observed. This variability seems to be due to a certain inaccuracy of the clinical criteria currently used for the diagnosis of vagal syncope and consequently for the definition of the inclusion and exclusion criteria used for patient recruitment in our study. Therefore, future studies on this topic, in particular those aiming at clarifying the association between muscarinic receptor overexpression and vagal pathologies, will likely benefit from greater precision of inclusion and exclusion criteria.

Studies have shown the implication of genetic transmission in reflex syncope \[[@pone.0219598.ref033],[@pone.0219598.ref034]\]. So far, whether overexpression of M~2~R or AchE might be due to genetic mutations or secondary to excessive acetylcholine release remains unexplored. A clinical study is yet ongoing to determine the role of genetics in reflex syncope.

Conclusion {#sec023}
==========

In adults, as in children, M~2~R overexpression appears as a hallmark of VO. Our work helps to understand the pathophysiology of VO. For the first time, biological abnormalities have been identified in pathologies in which, until now, only clinical elements were taken into account for the differential diagnosis and therapeutic management. Further work will be needed to validate potential biomarkers of risk or severity associated with the cholinergic system. This could lead to better management of reflex syncope.

These abnormalities are also observed in other human pathologies, such as SIDS or idiopathic apparent life-threatening event (iALTE) \[[@pone.0219598.ref014],[@pone.0219598.ref017]\]. Ours results open the path to forthcoming studies aiming validating M~2~R expression as a biological marker of these pathologies.
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